Blogs

Latest Blogs

The Silence of the Genes: Unlocking Antisense Oligonucleotide Therapies for the Renin-Angiotensin-Aldosterone System

The field of gene therapy is rapidly evolving, with antisense oligonucleotide therapies emerging as powerful tools for modulating gene expression.…

What are Immune Checkpoint Inhibitors?

Diseases, especially cancer, suppress the immune system and compromise the body’s biological mechanisms needed to defend itself from the disease…

Where Does Bioanalysis Fit into Drug Discovery Pipelines?

Bioanalysis is foundational for investigational therapeutic agents. This blog post will define the bioanalysis of molecules and highlight its beneficial…

A Quick Guide to Biomarker Solutions

Biomarker solutions cover a range of technologies, from modern diagnostic tools which make biological traits accessible, to analytical systems underpinning…

Fibrosis and SMAD signalling

During normal physiological wound healing, inflammation, angiogenesis and fibrogenesis are all effectively controlled, so that once sufficient matrix has accumulated…

Lipids as Biomarkers of Brain Disorders

Whilst the role of lipids has been particularly relevant within cardiovascular disease, their abundance in the body and high prevalence…

Synexa raises awareness for Rare Diseases Day

28 February 2022 marks Rare Disease Awareness Day and here at Synexa Life Sciences we are sharing our colours to…

Quick Links

Talk to our Biomarker Experts